AI assistant
Sending…
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012
Jun 1, 2012
29864_dirs_2012-06-01_324c299f-1f4a-47f6-8031-9946ed1b61b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-06-01
Reporting Person: ULLIAN ELAINE (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-01 | Stock Option | $59.55 | A | 22500 | Acquired | 2022-05-31 | Common Stock (22500) | Direct |
Footnotes
F1: Fully vested.
More from VERTEX PHARMACEUTICALS INC / MA
Major Shareholding Notification
2026
May 14
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 13